From Evidence to Optimal Management: Focus on the Results and Implications of Landmark Clinical Trials Evaluating the Safety and Efficacy of Interleukin-Targeted Therapies in Patients with Moderate-to- Severe Atopic Dermatitis - Amy S. Paller, MD, MS